Skip to main content
. 2025 Jul 23;53(6):2681–2689. doi: 10.1007/s15010-025-02614-9

Table 3.

Risk score performance in the derivation cohort and the validation cohort (data shown are percentages)

Derivation cohort [n = 1588] Validation cohort [n = 796]
Score No. of patients (Proportion) SE SP PPV NPV AC PLR NLR Score No. of patients (Proportion) SE SP PPV NPV AC PLR NLR
 ≥ -4 1588 (100.0) 100.0 0.0 7.9 NaN 7.9 1.00 NaN  ≥  – 4 796 (100.0) 100.0 0.0 8.2 NaN 8.2 1.00 NaN
 ≥ -2 1492 (94.0) 100.0 6.6 8.5 100.0 14.0 1.07 0.00  ≥  – 2 741 (93.1) 100.0 7.5 8.8 100.0 15.1 1.08 0.00
 ≥ -1 1480 (93.2) 100.0 7.4 8.5 100.0 14.7 1.08 0.00  ≥  – 1 732 (92.0) 100.0 8.8 8.9 100.0 16.2 1.10 0.00
 ≥ 0 1184 (74.6) 94.4 27.2 10.1 98.3 32.5 1.30 0.20  ≥ 0 604 (75.9) 95.4 25.9 10.3 98.4 31.5 1.29 0.18
 ≥ 1 1159 (73.0) 94.4 28.9 10.3 98.4 34.1 1.33 0.19  ≥ 1 597 (75.0) 95.4 26.8 10.4 98.5 32.4 1.30 0.17
 ≥ 2 1090 (68.6) 93.7 33.5 10.8 98.4 38.3 1.41 0.19  ≥ 1 545 (68.5) 93.8 33.8 11.2 98.4 38.7 1.42 0.18
 ≥ 3 829 (52.2) 84.9 50.6 12.9 97.5 53.3 1.72 0.30  ≥ 3 467 (58.7) 90.8 44.2 12.6 98.2 48.0 1.63 0.21
 ≥ 4 610 (38.4) 79.4 65.1 16.4 97.3 66.3 2.28 0.32  ≥ 4 401 (50.4) 89.2 53.1 14.5 98.2 56.0 1.90 0.20
 ≥ 5 521 (32.8) 74.6 70.8 18.0 97.0 71.1 2.55 0.36  ≥ 5 336 (42.2) 83.1 61.4 16.1 97.6 63.2 2.15 0.28
 ≥ 6 438 (27.6) 68.3 75.9 19.6 96.5 75.3 2.83 0.42  ≥ 6 248 (31.2) 67.7 72.1 17.7 96.2 71.7 2.43 0.45
 ≥ 7 253 (15.9) 51.6 87.1 25.7 95.4 84.3 4.01 0.56  ≥ 7 171 (21.5) 61.5 82.1 23.4 96.0 80.4 3.43 0.47
 ≥ 8 208 (13.1) 44.4 89.6 26.9 94.9 86.0 4.27 0.62  ≥ 8 147 (18.5) 55.4 84.8 24.5 95.5 82.4 3.65 0.53
 ≥ 9 127 (8.0) 29.4 93.8 29.1 93.9 88.7 4.77 0.75  ≥ 9 79 (9.9) 29.2 91.8 24.1 93.6 86.7 3.56 0.77
 ≥ 10 98 (6.2) 24.6 95.4 31.6 93.6 89.9 5.37 0.79  ≥ 10 57 (7.2) 23.1 94.3 26.3 93.2 88.4 4.02 0.82
 ≥ 11 75 (4.7) 19.8 96.6 33.3 93.3 90.5 5.80 0.83  ≥ 11 31 (4.0) 15.4 97.1 32.3 92.8 90.5 5.36 0.87
 ≥ 12 37 (2.3) 11.1 98.4 37.8 92.8 91.5 7.06 0.90  ≥ 12 24 (3.0) 13.8 97.9 37.5 92.7 91.1 6.75 0.88
 ≥ 13 29 (1.8) 10.3 98.9 44.8 92.8 91.9 9.43 0.91  ≥ 13 15 (1.9) 10.8 98.9 46.7 92.6 91.7 9.84 0.90
 ≥ 14 7 (0.4) 2.4 99.7 42.9 92.2 92.0 8.70 0.98  ≥ 14 5 (0.6) 4.6 99.7 60.0 92.2 92.0 16.87 0.96
 ≥ 15 6 (0.4) 1.6 99.7 33.3 92.2 92.0 5.85 0.99  ≥ 15 4 (0.5) 3.1 99.7 50.0 92.0 91.8 11.25 0.97
 ≥ 16 4 (0.3) 0.8 99.8 25.0 92.1 91.9 3.87 0.99  ≥ 16 3 (0.4) 3.1 99.9 66.7 92.1 92.0 22.49 0.97
 ≥ 18 1 (0.1) 1.5 100.0 100.0 91.9 92.0 Inf 0.98

n Number of patients, No. Number, SE Sensitivity, SP Specificity, PPV Positive Predictive Value, NPV Negative Predictive Value, AC Accuracy, PLR Positive Likelihood Ratio, NLR Negative Likelihood Ratio, NaN Not a Number, Inf Infinity